title: Next-generation therapeutic solutions for age-related macular degeneration.
abstract: Age-related macular degeneration (AMD) is the primary cause of irreversible blindness among the elderly in the western world. To date, no cure is available and the current anti-VEGF therapy has only shown limited efficacy in improving visual acuity in neovascular AMD. The etiology of AMD remains elusive but research over the past decade has uncovered characteristic features of the disease. These features include: oxidative stress and retinal pigment epithelial cell cytotoxicity; loss of macromolecular permeability and hydraulic conductivity in Bruch's membrane; inflammation; choroidal neovascularization and vascular leakage; and loss of neuroprotection. Recent breakthroughs in understanding the pathogenesis of AMD have spawned an array of novel therapeutic agents designed to address these hallmarks. Here we review the features of AMD and highlight the most promising therapeutic and diagnostic approaches based on the patents published from 2008 to 2011.
authors.forename: Khrishen
authors.initials: K
authors.lastname: Cunnusamy
authors.forename: Rafael
authors.initials: R
authors.lastname: Ufret-Vincenty
authors.forename: Shusheng
authors.initials: S
authors.lastname: Wang
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001766:Blindness / Q000517:prevention & control; D015195:Drug Design; D006801:Humans; D008268:Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D010330:Patents as Topic; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A
references.citation: Ophthalmic Epidemiol. 2004 Apr;11(2):67-115
references.pmid: 15255026
references.citation: Transpl Immunol. 2000 Nov;8(3):153-9
references.pmid: 11147695
references.citation: Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2599-605
references.pmid: 18296663
references.citation: N Engl J Med. 2008 Jun 12;358(24):2606-17
references.pmid: 18550876
references.citation: Physiol Rev. 2005 Jul;85(3):845-81
references.pmid: 15987797
references.citation: J Mol Med (Berl). 2011 Apr;89(4):343-61
references.pmid: 21170513
references.citation: PLoS One. 2011 Feb 22;6(2):e16733
references.pmid: 21364932
references.citation: Mol Vis. 2007 May 23;13:772-8
references.pmid: 17563727
references.citation: PLoS One. 2011 Apr 28;6(4):e19078
references.pmid: 21552568
references.citation: Science. 2009 Jan 9;323(5911):256-9
references.pmid: 19131628
references.citation: Hum Mol Genet. 2005 Jun 1;14(11):1449-55
references.pmid: 15829498
references.citation: Mol Cell Proteomics. 2009 Aug;8(8):1921-33
references.pmid: 19435712
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16227-32
references.pmid: 17884985
references.citation: Nat Genet. 2008 Jul;40(7):892-6
references.pmid: 18511946
references.citation: Science. 2005 Apr 15;308(5720):419-21
references.pmid: 15761120
references.citation: Science. 2005 Apr 15;308(5720):385-9
references.pmid: 15761122
references.citation: Prog Retin Eye Res. 2009 Jan;28(1):1-18
references.pmid: 19026761
references.citation: FASEB J. 2010 May;24(5):1552-71
references.pmid: 20056717
references.citation: Retina. 2010 Oct;30(9):1350-67
references.pmid: 20924259
references.citation: Br J Ophthalmol. 2002 Feb;86(2):214-9
references.pmid: 11815350
references.citation: Curr Opin Ophthalmol. 2011 May;22(3):190-3
references.pmid: 21427574
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):E279-87
references.pmid: 21690377
references.citation: Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1981-9
references.pmid: 10845625
references.citation: N Engl J Med. 2008 Oct 2;359(14):1456-63
references.pmid: 18753640
references.citation: Am J Physiol Cell Physiol. 2009 Dec;297(6):C1452-65
references.pmid: 19794146
references.citation: Aging (Albany NY). 2010 Dec;2(12):981-9
references.pmid: 21098885
references.citation: Front Biosci. 2005 Sep 01;10:2131-49
references.pmid: 15970483
references.citation: Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4226-36
references.pmid: 20220052
references.citation: Proc Natl Acad Sci U S A. 2011 May 17;108(20):8287-92
references.pmid: 21536891
references.citation: Br J Ophthalmol. 2008 Apr;92(4):537-40
references.pmid: 18310311
references.citation: Invest Ophthalmol Vis Sci. 2002 Dec;43(12):3744-53
references.pmid: 12454046
references.citation: Hum Mol Genet. 2001 Nov 1;10(23):2671-8
references.pmid: 11726554
references.citation: Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8159-63
references.pmid: 1654560
references.citation: J Neurosci. 2009 Apr 8;29(14):4356-68
references.pmid: 19357264
references.citation: Prog Retin Eye Res. 2010 Jan;29(1):1-18
references.pmid: 19747980
references.citation: Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3842-53
references.pmid: 21330654
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7154-9
references.pmid: 10852960
references.citation: Trends Mol Med. 2008 Dec;14(12):511-21
references.pmid: 18977695
references.citation: N Engl J Med. 2007 Aug 9;357(6):553-61
references.pmid: 17634448
references.citation: Neurology. 2010 Jan 5;74 Suppl 1:S25-30
references.pmid: 20038760
references.citation: N Engl J Med. 2006 Oct 5;355(14):1474-85
references.pmid: 17021323
references.citation: Curr Opin Genet Dev. 2009 Jun;19(3):205-11
references.pmid: 19446450
references.citation: Nat Med. 1997 Mar;3(3):346-9
references.pmid: 9055866
references.citation: Brain Res. 1995 May 15;679(2):249-54
references.pmid: 7543356
references.citation: Invest Ophthalmol Vis Sci. 2006 Jan;47(1):329-35
references.pmid: 16384981
references.citation: Invest Ophthalmol Vis Sci. 2008 May;49(5):2143-7
references.pmid: 18436847
references.citation: Adv Exp Med Biol. 2010;703:137-49
references.pmid: 20711712
references.citation: Hum Mutat. 2006 Apr;27(4):337-42
references.pmid: 16453339
references.citation: Arch Ophthalmol. 2004 Apr;122(4):564-72
references.pmid: 15078675
references.citation: Am J Epidemiol. 1993 Jan 15;137(2):190-200
references.pmid: 8452123
references.citation: Adv Exp Med Biol. 2010;703:9-24
references.pmid: 20711704
references.citation: Immunity. 2011 May 27;34(5):637-50
references.pmid: 21616434
references.citation: PLoS Biol. 2008 Sep 30;6(9):e236
references.pmid: 18828673
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3842-7
references.pmid: 11904436
references.citation: Ophthalmologica. 2009;223(6):401-10
references.pmid: 19622904
references.citation: Curr Eye Res. 2010 Nov;35(11):941-52
references.pmid: 20958182
references.citation: Nat Med. 2008 Feb;14(2):194-8
references.pmid: 18223656
references.citation: Science. 1997 Sep 19;277(5333):1805-7
references.pmid: 9295268
references.citation: Am J Ophthalmol. 2008 Apr;145(4):716-721
references.pmid: 18226801
references.citation: Invest Ophthalmol Vis Sci. 1994 Nov;35(12):4100-8
references.pmid: 7960592
references.citation: Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1526-30
references.pmid: 8434014
references.citation: Toxicol Pathol. 2008 Jan;36(1):49-62
references.pmid: 18337221
references.citation: Nat Genet. 2006 Apr;38(4):458-62
references.pmid: 16518403
references.citation: Am J Ophthalmol. 2008 Jun;145(6):1045-1051
references.pmid: 18378209
references.citation: N Engl J Med. 2004 Jul 22;351(4):346-53
references.pmid: 15269314
references.citation: Nat Nanotechnol. 2006 Nov;1(2):142-50
references.pmid: 18654167
references.citation: Ann Med. 2006;38(7):450-71
references.pmid: 17101537
references.citation: Hum Mol Genet. 2006 Oct 1;15(19):2955-61
references.pmid: 16940309
references.citation: Science. 2005 Apr 15;308(5720):421-4
references.pmid: 15761121
references.citation: Semin Ophthalmol. 2011 May;26(3):192-7
references.pmid: 21609232
references.citation: Nature. 2011 Oct 05;478(7367):76-81
references.pmid: 21979047
references.citation: Nature. 2011 Mar 17;471(7338):325-30
references.pmid: 21297615
references.citation: Transplantation. 2008 May 27;85(10):1372-7
references.pmid: 18497672